Eurofins Scientific SE (ERFSF)
USD 49.72
(0.0%)
USD 49.72
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.51 Billion EUR | -2.94% |
| 2022 | 6.71 Billion EUR | -0.08% |
| 2021 | 6.71 Billion EUR | 23.51% |
| 2020 | 5.43 Billion EUR | 19.2% |
| 2019 | 4.56 Billion EUR | 20.67% |
| 2018 | 3.78 Billion EUR | 27.25% |
| 2017 | 2.97 Billion EUR | 17.14% |
| 2016 | 2.53 Billion EUR | 30.08% |
| 2015 | 1.95 Billion EUR | 38.28% |
| 2014 | 1.41 Billion EUR | 15.07% |
| 2013 | 1.22 Billion EUR | 17.4% |
| 2012 | 1.04 Billion EUR | 25.94% |
| 2011 | 828.93 Million EUR | 21.84% |
| 2010 | 680.33 Million EUR | 6.29% |
| 2009 | 640.07 Million EUR | 1.16% |
| 2008 | 632.75 Million EUR | 28.67% |
| 2007 | 491.77 Million EUR | 33.64% |
| 2006 | 367.99 Million EUR | 57.86% |
| 2005 | 233.1 Million EUR | 32.81% |
| 2004 | 175.51 Million EUR | 4.06% |
| 2003 | 168.67 Million EUR | 4.37% |
| 2002 | 161.6 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 3.41 Billion EUR | 0.0% |
| 2023 Q2 | 3.2 Billion EUR | 0.0% |
| 2023 FY | 6.51 Billion EUR | -2.94% |
| 2023 Q4 | 3.3 Billion EUR | 0.0% |
| 2022 Q4 | 3.3 Billion EUR | 0.0% |
| 2022 FY | 6.71 Billion EUR | -0.08% |
| 2022 Q2 | 3.41 Billion EUR | 0.0% |
| 2021 FY | 6.71 Billion EUR | 23.51% |
| 2021 Q2 | 3.27 Billion EUR | 0.0% |
| 2021 Q4 | 3.44 Billion EUR | 0.0% |
| 2020 Q4 | 3.11 Billion EUR | 0.0% |
| 2020 FY | 5.43 Billion EUR | 19.2% |
| 2020 Q2 | 2.32 Billion EUR | 0.0% |
| 2019 Q2 | 2.16 Billion EUR | 0.0% |
| 2019 FY | 4.56 Billion EUR | 20.67% |
| 2019 Q4 | 2.39 Billion EUR | 0.0% |
| 2018 Q2 | 1.74 Billion EUR | 0.0% |
| 2018 FY | 3.78 Billion EUR | 27.25% |
| 2018 Q4 | 2.03 Billion EUR | 0.0% |
| 2017 Q2 | 1.39 Billion EUR | 0.0% |
| 2017 Q4 | 1.57 Billion EUR | 0.0% |
| 2017 FY | 2.97 Billion EUR | 17.14% |
| 2016 Q2 | 1.2 Billion EUR | 0.0% |
| 2016 Q4 | 1.32 Billion EUR | 0.0% |
| 2016 FY | 2.53 Billion EUR | 30.08% |
| 2015 FY | 1.95 Billion EUR | 38.28% |
| 2015 Q2 | 841.9 Million EUR | 0.0% |
| 2015 Q4 | 1.1 Billion EUR | 0.0% |
| 2014 FY | 1.41 Billion EUR | 15.07% |
| 2014 Q4 | 766.72 Million EUR | 0.0% |
| 2014 Q2 | 643.5 Million EUR | 0.0% |
| 2013 Q4 | 655.31 Million EUR | 0.0% |
| 2013 Q2 | 570.26 Million EUR | 0.0% |
| 2013 FY | 1.22 Billion EUR | 17.4% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 FY | 1.04 Billion EUR | 25.94% |
| 2011 Q1 | 164.3 Million EUR | -67.46% |
| 2011 Q4 | 243.11 Million EUR | 13.74% |
| 2011 Q2 | 207.77 Million EUR | 26.46% |
| 2011 Q3 | 213.74 Million EUR | 2.87% |
| 2011 FY | 828.93 Million EUR | 21.84% |
| 2010 Q1 | 149.1 Million EUR | -68.74% |
| 2010 Q2 | 169.44 Million EUR | 13.64% |
| 2010 Q3 | 493.97 Million EUR | 191.52% |
| 2010 Q4 | 504.91 Million EUR | 2.21% |
| 2010 FY | 680.33 Million EUR | 6.29% |
| 2009 FY | 640.07 Million EUR | 1.16% |
| 2009 Q4 | 476.98 Million EUR | 1.9% |
| 2009 Q3 | 468.1 Million EUR | 198.59% |
| 2009 Q1 | 148.24 Million EUR | 0.0% |
| 2009 Q2 | 156.77 Million EUR | 5.75% |
| 2008 FY | 632.75 Million EUR | 28.67% |
| 2007 FY | 491.77 Million EUR | 33.64% |
| 2006 FY | 367.99 Million EUR | 57.86% |
| 2005 FY | 233.1 Million EUR | 32.81% |
| 2004 FY | 175.51 Million EUR | 4.06% |
| 2003 FY | 168.67 Million EUR | 4.37% |
| 2002 FY | 161.6 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -713437.788% |
| Arrayit Corporation | 4.37 Million USD | -148726.902% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | -25093.75% |
| Bioqual, Inc. | 58.59 Million USD | -11018.782% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | -42490.22% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 11.775% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -102230.739% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -619399.995% |
| Interpace Biosciences, Inc. | 40.21 Million USD | -16099.831% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -1455679.789% |
| InVitro International | 792.62 Thousand USD | -821798.797% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | -58426.637% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -90077.135% |
| NovelStem International Corp. | 12 Thousand USD | -54288233.333% |
| Optigenex Inc. | 465.97 Thousand USD | -1397972.837% |
| PharmChem, Inc. | 6.01 Million USD | -108252.684% |
| Proteome Sciences plc | 6.4 Million USD | -101680.383% |
| Response Genetics, Inc | 18.04 Million USD | -36011.973% |
| Rennova Health, Inc. | 13.03 Million USD | -49873.259% |
| RushNet, Inc. | 1.78 Million USD | -364275.685% |
| ScreenPro Security Inc. | 1.91 Million USD | -340247.411% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -171559.276% |
| Todos Medical Ltd. | 7.69 Million USD | -84560.169% |